Acute Kidney Injury after Pembrolizumab-Induced Adrenalitis and Adrenal Insufficiency

Acute Kidney Injury after Pembrolizumab-Induced Adrenalitis and Adrenal Insufficiency

Pembrolizumab is an immune checkpoint inhibitor that targets the programmed cell death protein 1 (PD-1) antigen and induces an immune response against tumor tissues. It has been successful in inducing remission in patients with severe metastatic disease, often refractory to other chemotherapeutic ag...

Full description

Bibliographic Details
Main Authors: Ramy M. Hanna, Umut Selamet, Patrick Bui, Shih-Fan Sun, Olivia Shenouda, Niloofar Nobakht, Marina Barsoum, Farid Arman, Anjay Rastogi
Format: Article
Language:English
Published: Karger Publishers 2018-08-01
Series:Case Reports in Nephrology and Dialysis
Subjects:
Pembrolizumab
Adrenalitis
Adrenal insufficiency
Immune checkpoint inhibitor therapy
PD-1
PD-L1
CTL-4 inhibitors
Acute kidney injury
Acute tubular necrosis
Online Access:https://www.karger.com/Article/FullText/491631

Internet

https://www.karger.com/Article/FullText/491631

Similar Items